Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-19-018060)

Filing Details

Accession Number:: 0001437749-19-018060
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-09 13:11:49
Reporting Period:: 2019-09-05

Accepted Time:: 2019-09-09 13:11:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595248	Genprex Inc.	GNPX	Pharmaceutical Preparations (2834)	900772347

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1735543	Rodney John Varner	1601 Trinity Street Bldg B, Suite 3.322 Austin TX 78712	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-05	1,800	$0.89	1,800	No	4	P	Indirect	by Alizzita Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by Alizzita Ltd.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,614,152	Indirect	by Laura Lane Biosciences, LLC
Common Stock	544,735	Direct

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8856 per share to $0.8880 per share. A total of 100 shares were purchased at $0.8856 per share, a total of 1,500 shares were purchased at $0.8858 per shares, a total of 100 shares were purchased at $0.8859 per share, and a total of 100 shares were purchased at $0.8880 per share.